Publications by authors named "Silvia Bolis"

Claim this Profile
E
Erratum: Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi, Caterina Patti, Silvia Bolis

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.
Rexhep Durmo, Stephane Chauvie, Federico Fallanca, Fabrizio Bergesio, Antonio Pinto, Silvia Bolis

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End of induction [F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Luca Guerra, Stephane Chauvie, Federico Fallanca, Fabrizio Bergesio, Luigi Marcheselli, Silvia Anna Maria Bolis

Eur J Nucl Med Mol Imaging· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
Alessandro Pulsoni, Simone Ferrero, Maria Elena Tosti, Stefano Luminari, Alessandra Dondi, Silvia Anna Bolis

Lancet Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous pemphigoid-like rash induced by bendamustine.
Ivan Civettini, Silvia Anna Maria Bolis

Br J Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience.
Marina Moretti, Anna Marina Liberati, Luigi Rigacci, Benedetta Puccini, Alessandro Pulsoni, Silvia Bolis

Clin Lymphoma Myeloma Leuk· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study.
Stefano Luminari, Martina Manni, Sara Galimberti, Annibale Versari, Alessandra Tucci, Silvia Bolis

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Carola Boccomini, Marco Ladetto, Luigi Rigacci, Benedetta Puccini, Sara Rattotti, Silvia Bolis

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
Michele Merli, Stefano Luminari, Lucia Farina, Federica Cocito, Irene Defrancesco, Silvia Bolis

Bone Marrow Transplant· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial.
Alessandra Romano, Chiara Pavoni, Francesco Di Raimondo, Corrado Tarella, Simonetta Viviani, Silvia Bolis

Cancer Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
Andrea Gallamini, Andrea Rossi, Caterina Patti, Marco Picardi, Alessandra Romano, Silvia Bolis

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, Elisabetta Bonifacio, Francesca Pregnolato, Silvia Bolis

Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi, Caterina Patti, Silvia Bolis

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.
Colette Zwarthoed, Tarec Cristoffer El-Galaly, Maria Canepari, Matthieu John Ouvrier, Julien Viotti, Silvia Bolis

J Nucl Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implemented myeloma management with whole-body low-dose CT scan: a real life experience.
Silvia Mangiacavalli, Sara Pezzatti, Fausto Rossini, Elisa Doni, Federica Cocito, Silvia Bolis

Leuk Lymphoma· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Angelo Belotti, Elisa Doni, Silvia Bolis, Fausto Rossini, Ivana Casaroli

Clin Lymphoma Myeloma Leuk· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, Chiara Bottelli, Alessandra Tucci, Silvia Bolis

Am J Hematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Andrea Gallamini, Sally F Barrington, Alberto Biggi, Stephane Chauvie, Lale Kostakoglu, Silvia Bolis

Haematologica· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.
Paolo G Gobbi, Francesco Valentino, Emilio Bassi, Chiara Coriani, Francesco Merli, Silvia Bolis

Clin Lymphoma Myeloma Leuk· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of music therapy on psychological symptoms and heart rate variability in patients with dementia. A pilot study.
Alfredo Raglio, Osmano Oasi, Marta Gianotti, Veronica Manzoni, Silvia Bolis

Curr Aging Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis